M&A Deal Summary

Zogenix Acquires Modis Therapeutics

On August 26, 2019, Zogenix acquired life science company Modis Therapeutics from Eight Roads for 250M USD

Acquisition Highlights
  • This is Zogenix’s 2nd transaction in the Life Science sector.
  • This is Zogenix’s largest (disclosed) transaction.
  • This is Zogenix’s 1st transaction in the United States.
  • This is Zogenix’s 1st transaction in California.

M&A Deal Summary
Date 2019-08-26
Target Modis Therapeutics
Sector Life Science
Buyer(s) Zogenix
Sellers(s) Eight Roads
Deal Type Add-on Acquisition
Deal Value 250M USD

Target

Modis Therapeutics

Oakland, California, United States
Modis Therapeutics is a biopharmaceutical company focused on developing disease-modifying therapies for rare genetic diseases with a high unmet medical need. Modis program (MT1621) is in clinical development for TK2d, an inherited mitochondrial disease. Modis Therapeutics was founded in 2016 and is headquartered in Oakland, California, with offices in New York City.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Zogenix

Emeryville, California, United States
Category Company
Founded 2006
Sector Life Science
Employees218
Revenue 14M USD (2020)
DESCRIPTION

Zogenix is a pharmaceutical company focused on the development and commercialization of medicines to treat neuroscience disorders and pain. Zogenix was founded in 2006 and is based in Emeryville, California.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (California) 1 of 1
Country (United States) 1 of 1
Year (2019) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-27 Brabant Pharma

Manchester, United Kingdom

Brabant Pharma Ltd. is a pharmaceutical company.

Buy $20M

Seller(S) 1

SELLER

Eight Roads

Investor

Category Private Equity Firm
Founded 1969
Size Small
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.

DEAL STATS #
Overall 48 of 98
Sector (Life Science) 31 of 49
Type (Add-on Acquisition) 20 of 45
State (California) 6 of 16
Country (United States) 29 of 60
Year (2019) 5 of 7
Size (of disclosed) 11 of 19
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-07-31 Aperza

Yokohama, Japan

Aperza develops and operates price search, information distribution, and catalog download sites and portals for the manufacturing industry. Aperza is based in Yokohama, Japan.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-03 Semma Therapeutics

Cambridge, Massachusetts, United States

Semma Therapeutics is a privately held biotechnology company pioneering the use of stem cell-derived human islets as a potentially curative treatment for type 1 diabetes. Semma Therapeutics was formed in 2015 and is based in Cambridge, Massachusetts.

Sell $950M
Mergr

Product

Company

Legal